data13F

TEVA – Teva Pharmaceutical Ind Ltd

Held by 5 of 60 tracked investors in their latest 13F filing · 3 counted on Most owned (narrow-view filings excluded)

Investors holding5
Combined shares10,875,191
Combined reported value$430.7M

TEVA chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Larry Robbins 5.32 New7,566,877$299.6MQ3 2026
David Einhorn 2.03 New1,817,146$72.0MQ3 2026
Ray Dalio narrow view 0.17 New982,873$38.9MQ3 2026
Paul Tudor Jones narrow view 0.08 New440,000$17.4MQ3 2026
Cathie Wood 0.02 New68,295$2.7MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Larry Robbins New7,566,8775.32
Q3 2026David Einhorn New1,817,1462.03
Q3 2026Ray Dalio narrow view New982,8730.17
Q3 2026Paul Tudor Jones narrow view New440,0000.08
Q3 2026Cathie Wood New68,2950.02

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Larry Robbins New7,566,8775.32
Q3 2026David Einhorn New1,817,1462.03
Q3 2026Ray Dalio narrow view New982,8730.17
Q3 2026Paul Tudor Jones narrow view New440,0000.08
Q3 2026Cathie Wood New68,2950.02

Reduced: reduced or closed

No tracked investor reduced or closed this position in the last 4 quarters.

History

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Larry Robbins7.57M–––––––
David Einhorn1.82M–––––––
Ray Dalio982.9K–––––––
Paul Tudor Jones440.0K–––––––
Cathie Wood68.3K–––––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).